Skip to content

Risk Factors and Prognostic Analysis of Hypotension in Hemodialysis Patients with Superior Vena Cava Syndrome

Risk Factors and Prognostic Analysis of Hypotension in Hemodialysis Patients with Superior Vena Cava Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102834
Enrollment
Unknown
Registered
2025-05-20
Start date
2025-05-20
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superior Vena Cava Syndrome

Interventions

The hypotension group:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients who have been treated with continuous dialysis for more than 6 months meet the diagnostic criteria of superior vena cava syndrome at the same time.

Exclusion criteria

Exclusion criteria: (1)Women under the age of 18 and/or pregnant; (2)Patients with malignant tumor, arrhythmia, organic heart disease, myocardial amyloidosis, severe anemia, severe hypoproteinemia, terminal cachexia and incomplete clinical data; (3)Coma, mental or mental disorder can not cooperate.

Design outcomes

Primary

MeasureTime frame
blood pressure;Degree of superior vena cava stenosis;Stenosis of the superior vena cava;Types of vascular pathways;

Secondary

MeasureTime frame
Hemoglobin;Serum Albumin;Electrolyte;Renal function;Coagulation function indicators;C-reactive protein;Procalcitonin;Left ventricular ejection fraction;

Countries

China

Contacts

Public ContactCui Tianlei

West China Hospital of Sichuan University

tianleicui@163.com+86 189 8060 1979

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026